In this article by Adam H. Fleischer, the Chairperson of BatesCarey’s Opioid Coverage Task Force, we examine recent developments that have broadened the liabilities of pharmaceutical companies for the manufacture and distribution of prescription opioids and new questions as to whether opioid liability can be covered by insurance. Click here to read the article.